Novartis
NVS
830 hedge funds and large institutions have $20.6B invested in Novartis in 2014 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 309 increasing their positions, 318 reducing their positions, and 41 closing their positions.
49% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 41
15% more funds holding in top 10
Funds holding in top 10: 52 → 60 (+8)
2% more funds holding
Funds holding: 815 → 830 (+15)
4% more capital invested
Capital invested by funds: $19.8B → $20.6B (+$742M)
0.17% less ownership
Funds ownership: 9.99% → 9.82% (-0.17%)
3% less repeat investments, than reductions
Existing positions increased: 309 | Existing positions reduced: 318
5% less call options, than puts
Call options by funds: $182M | Put options by funds: $192M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$68.5M |
| 2 |
MHI
Miller Howard Investments
Kingston,
New York
|
+$56.8M |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$48.7M |
| 4 |
AG
Aperio Group
Sausalito,
California
|
+$43.8M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$220M |
| 2 |
Neuberger Berman Group
New York
|
-$137M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$96.5M |
| 4 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$70.6M |
| 5 |
HTC
Haverford Trust Company
Radnor,
Pennsylvania
|
-$67.3M |
NVS Hedge Fund Activity: Q1 2014 in Review
830 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q1 2014, worth a combined $20.6B — up 3.7% from $19.8B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new NVS positions and 41 closed out — a net gain of 20 holders — while 309 added to existing stakes and 318 trimmed.
The largest buyer was Loomis, Sayles & Company, adding an estimated $68.5M. The largest seller was Primecap Management, cutting an estimated $220M.
- 830 institutional investors held Novartis (NVS) as of Q1 2014, up from 815 in Q4 2013.
- Funds reported $20.6B of Novartis stock for Q1 2014, up 3.7% quarter-over-quarter.
- 61 funds opened new Novartis positions in Q1 2014 and 41 closed out, a net change of +20 holders.
- The largest Novartis buyer in Q1 2014 was Loomis, Sayles & Company, an estimated $68.5M added.
- The largest Novartis seller in Q1 2014 was Primecap Management, an estimated $220M sold.
Based on aggregated 13F filings for Q1 2014.